Skip to main content
Molecular Medicine logoLink to Molecular Medicine
. 2020 Dec 30;26:132. doi: 10.1186/s10020-020-00265-0

Retraction Note: The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Ravikumar A Sitapara 1, Daniel J Antoine 2, Lokesh Sharma 1, Vivek S Patel 1, Charles R Ashby Jr 1, Samir Gorasiya 1, Huan Yang 3, Michelle Zur 1, Lin L Mantell 1,4,5,
PMCID: PMC7772916  PMID: 33380316

Retraction Note to: Mol Med (2014) 20:238–247 https://doi.org/10.2119/molmed.2013.00086

The Editors-in-Chief have retracted this article (Sitapara et al. 2014) following an investigation by the University of Liverpool. The investigation concluded that the mass spectra data contained in Fig. 4 demonstrate evidence of data manipulation, duplicate publication and figure fabrication and are thus unreliable. The mass spectra published in Fig. 4c are identical to mass-spectra published in Supplementary Fig. 2 from another publication (Wang et al. (2015)) and Fig. 3c in (Entezari et al. (2014)). In addition to this, there are inconsistencies between mass stated on the spectral peaks and the m/z (Da) value on the x-axis. There is also further possible figure duplication with some adjustment to the size of the peaks and labels. There is obvious similarity between spectra published in Fig. 4b in (Sitapara et al. 2014) and the spectra published in Fig. 3c in (Ju et al. 2014), with some alterations in peak size and mass labelling. There is further circumstantial evidence of research misconduct through inconsistencies in data produced by specific mass-spectrometers as detailed in the figure. The co-authors of the article were found by the investigation not to be complicit in any research misconduct, and they have been invited to resubmit a revised version of the manuscript for further peer review. More information on the university's investigation can be found on the university website (Further update on research misconduct investigation 2020).

All authors agree to this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Entezari M, Javdan M, Antoine DJ, Morrow DM, Sitapara RA, Patel V, Wang M, Sharma L, Gorasiya S, Zur M, Wu W. Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury. Redox Biol. 2014;2:314–322. doi: 10.1016/j.redox.2014.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ju Z, Chavan SS, Antoine DJ, Dancho M, Tsaava T, Li J, Lu B, Levine YA, Stiegler A, Tamari Y, Al-Abed Y. Sequestering HMGB1 via DNA-conjugated beads ameliorates murine colitis. PLoS ONE. 2014;9:8. doi: 10.1371/journal.pone.0103992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Further update on research misconduct investigation, 17 August 2020. https://news.liverpool.ac.uk/2020/08/17/further-update-on-research-misconduct-investigation/
  4. Sitapara RA, Antoine DJ, Sharma L, Patel VS, Ashby CR, Gorasiya S, Yang H, Zur M, Mantell LL. The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med. 2014;20:238–247. doi: 10.2119/molmed.2013.00086. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  5. Wang M, Gorasiya S, Antoine DJ, Sitapara RA, Wu W, Sharma L, Yang H, Ashby CR, Vasudevan D, Zur M, Thomas DD. The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB–mediated release of high-mobility group box-1. Am J Respir Cell Mol Biol. 2015;52(2):171–82. doi: 10.1165/rcmb.2013-0544OC. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES